Almost a decade after reverse-payment agreements were established to be potentially anticompetitive by the US Supreme Court, a new era of even tougher scrutiny of patent litigation settlements may be about to begin. The current commissioners at the FTC are looking to broaden their entire view of what constitutes anticompetitive harm says Goodwin Antitrust and Competition partner Andy Lacy. Read the Intellectual Asset Management article here.